vs
Cooper Companies (The)（COO）与National Vision Holdings, Inc.（EYE）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是National Vision Holdings, Inc.的2.2倍（$1.1B vs $487.3M）。Cooper Companies (The)净利率更高（7.9% vs 0.7%，领先7.3%）。National Vision Holdings, Inc.同比增速更快（7.9% vs 4.6%）。Cooper Companies (The)自由现金流更多（$149.9M vs $30.3M）。过去两年National Vision Holdings, Inc.的营收复合增速更高（7.6% vs 6.9%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
Vision Research是一家总部位于美国新泽西州韦恩的跨国企业，主营高速数码相机的研发生产，旗下产品以Phantom品牌推向市场，广泛应用于国防、工业产品开发、制造、汽车、科研、娱乐等众多领域，目前隶属于全球电子仪器及机电设备制造商阿美特克公司的材料分析事业部。
COO vs EYE — 直观对比
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $487.3M |
| 净利润 | $84.6M | $3.4M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 2.0% |
| 净利率 | 7.9% | 0.7% |
| 营收同比 | 4.6% | 7.9% |
| 净利润同比 | -28.0% | 139.8% |
| 每股收益（稀释后） | $0.42 | $0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $487.3M | ||
| Q2 25 | $1.0B | $486.4M | ||
| Q1 25 | $964.7M | $510.3M | ||
| Q4 24 | $1.0B | $437.3M | ||
| Q3 24 | $1.0B | $451.5M | ||
| Q2 24 | $942.6M | $451.7M | ||
| Q1 24 | $931.6M | $482.8M |
| Q4 25 | $84.6M | — | ||
| Q3 25 | $98.3M | $3.4M | ||
| Q2 25 | $87.7M | $8.7M | ||
| Q1 25 | $104.3M | $14.2M | ||
| Q4 24 | $117.5M | $-28.6M | ||
| Q3 24 | $104.7M | $-8.5M | ||
| Q2 24 | $88.9M | $-3.1M | ||
| Q1 24 | $81.2M | $11.7M |
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — | ||
| Q1 24 | 67.0% | — |
| Q4 25 | 13.2% | — | ||
| Q3 25 | 16.6% | 2.0% | ||
| Q2 25 | 18.4% | 3.4% | ||
| Q1 25 | 18.9% | 5.1% | ||
| Q4 24 | 19.5% | -5.8% | ||
| Q3 24 | 19.2% | -2.0% | ||
| Q2 24 | 17.2% | 0.1% | ||
| Q1 24 | 16.4% | 4.9% |
| Q4 25 | 7.9% | — | ||
| Q3 25 | 9.3% | 0.7% | ||
| Q2 25 | 8.7% | 1.8% | ||
| Q1 25 | 10.8% | 2.8% | ||
| Q4 24 | 11.5% | -6.5% | ||
| Q3 24 | 10.4% | -1.9% | ||
| Q2 24 | 9.4% | -0.7% | ||
| Q1 24 | 8.7% | 2.4% |
| Q4 25 | $0.42 | — | ||
| Q3 25 | $0.49 | $0.04 | ||
| Q2 25 | $0.44 | $0.11 | ||
| Q1 25 | $0.52 | $0.18 | ||
| Q4 24 | $0.59 | $-0.36 | ||
| Q3 24 | $0.52 | $-0.11 | ||
| Q2 24 | $0.44 | $-0.04 | ||
| Q1 24 | $0.41 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $56.0M |
| 总债务越低越好 | $2.5B | $236.5M |
| 股东权益账面价值 | $8.2B | $858.8M |
| 总资产 | $12.4B | $2.0B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.28× |
8季度趋势，按日历期对齐
| Q4 25 | $110.6M | — | ||
| Q3 25 | $124.9M | $56.0M | ||
| Q2 25 | $116.2M | $48.5M | ||
| Q1 25 | $100.9M | $80.0M | ||
| Q4 24 | $107.6M | $73.9M | ||
| Q3 24 | $109.7M | $81.2M | ||
| Q2 24 | $112.4M | $179.5M | ||
| Q1 24 | $135.2M | $150.1M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | $236.5M | ||
| Q2 25 | $2.5B | $255.6M | ||
| Q1 25 | $2.5B | $244.7M | ||
| Q4 24 | $2.6B | $248.6M | ||
| Q3 24 | $2.6B | $252.8M | ||
| Q2 24 | $2.7B | $143.9M | ||
| Q1 24 | $2.7B | $448.6M |
| Q4 25 | $8.2B | — | ||
| Q3 25 | $8.4B | $858.8M | ||
| Q2 25 | $8.3B | $850.6M | ||
| Q1 25 | $8.1B | $836.2M | ||
| Q4 24 | $8.1B | $816.3M | ||
| Q3 24 | $7.9B | $840.0M | ||
| Q2 24 | $7.8B | $843.4M | ||
| Q1 24 | $7.7B | $841.3M |
| Q4 25 | $12.4B | — | ||
| Q3 25 | $12.4B | $2.0B | ||
| Q2 25 | $12.4B | $2.0B | ||
| Q1 25 | $12.2B | $2.0B | ||
| Q4 24 | $12.3B | $2.0B | ||
| Q3 24 | $12.1B | $2.0B | ||
| Q2 24 | $12.0B | $2.1B | ||
| Q1 24 | $12.0B | $2.2B |
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.29× | 0.28× | ||
| Q2 25 | 0.30× | 0.30× | ||
| Q1 25 | 0.31× | 0.29× | ||
| Q4 24 | 0.32× | 0.30× | ||
| Q3 24 | 0.33× | 0.30× | ||
| Q2 24 | 0.34× | 0.17× | ||
| Q1 24 | 0.35× | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $46.6M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $30.3M |
| 自由现金流率自由现金流/营收 | 14.1% | 6.2% |
| 资本支出强度资本支出/营收 | 9.2% | 3.4% |
| 现金转化率经营现金流/净利润 | 2.93× | 13.83× |
| 过去12个月自由现金流最近4个季度 | $433.7M | $83.0M |
8季度趋势，按日历期对齐
| Q4 25 | $247.9M | — | ||
| Q3 25 | $261.4M | $46.6M | ||
| Q2 25 | $96.2M | $54.3M | ||
| Q1 25 | $190.6M | $32.2M | ||
| Q4 24 | $268.1M | $30.3M | ||
| Q3 24 | $207.5M | $27.9M | ||
| Q2 24 | $111.0M | $51.5M | ||
| Q1 24 | $122.7M | $24.0M |
| Q4 25 | $149.9M | — | ||
| Q3 25 | $164.5M | $30.3M | ||
| Q2 25 | $18.1M | $42.4M | ||
| Q1 25 | $101.2M | $12.0M | ||
| Q4 24 | $128.1M | $-1.7M | ||
| Q3 24 | $118.5M | $4.1M | ||
| Q2 24 | $36.9M | $31.9M | ||
| Q1 24 | $4.6M | $4.0M |
| Q4 25 | 14.1% | — | ||
| Q3 25 | 15.5% | 6.2% | ||
| Q2 25 | 1.8% | 8.7% | ||
| Q1 25 | 10.5% | 2.4% | ||
| Q4 24 | 12.6% | -0.4% | ||
| Q3 24 | 11.8% | 0.9% | ||
| Q2 24 | 3.9% | 7.1% | ||
| Q1 24 | 0.5% | 0.8% |
| Q4 25 | 9.2% | — | ||
| Q3 25 | 9.1% | 3.4% | ||
| Q2 25 | 7.8% | 2.4% | ||
| Q1 25 | 9.3% | 4.0% | ||
| Q4 24 | 13.7% | 7.3% | ||
| Q3 24 | 8.9% | 5.3% | ||
| Q2 24 | 7.9% | 4.3% | ||
| Q1 24 | 12.7% | 4.1% |
| Q4 25 | 2.93× | — | ||
| Q3 25 | 2.66× | 13.83× | ||
| Q2 25 | 1.10× | 6.22× | ||
| Q1 25 | 1.83× | 2.27× | ||
| Q4 24 | 2.28× | — | ||
| Q3 24 | 1.98× | — | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.51× | 2.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
EYE
暂无分部数据
